Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparison to 51 non-infected patients revealed 221 differ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :eLife
Главные авторы: Gisby, Jack, Clarke, Candice L, Medjeral-Thomas, Nicholas, Malik, Talat H, Papadaki, Artemis, Mortimer, Paige M, Buang, Norzawani B, Lewis, Shanice, Pereira, Marie, Toulza, Frederic, Fagnano, Ester, Mawhin, Marie-Anne, Dutton, Emma E, Tapeng, Lunnathaya, Richard, Arianne C, Kirk, Paul DW, Behmoaras, Jacques, Sandhu, Eleanor, McAdoo, Stephen P, Prendecki, Maria F, Pickering, Matthew C, Botto, Marina, Willicombe, Michelle, Thomas, David C, Peters, James E
Формат: Artigo
Язык:Inglês
Опубликовано: eLife Sciences Publications, Ltd 2021
Предметы:
Immunology and Inflammation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064756/
https://ncbi.nlm.nih.gov/pubmed/33704068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.64827
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы